Analyst Coverage

Analyst Coverage

The following research analysts cover Destiny Pharma.

Mark Brewer, finnCap +44(0)20 7220 0500
Andy Smith, Equity Development +44(0)20 7065 2690


Please click on links below to access coverage published:

finnCap finnCap

Analyst research from finnCap can be obtained by registering on the link above

17 September 2020 – Interims – on track for Q1 2021 Phase 2b readout

7 September 2020 – Co-development collaboration and Innovate UK grant

Equity Development Equity Development

07 June 2021 – Encouraging AGM and M3 updates

04 May 2021 – M3: Another gem in the portfolio

Destiny Pharma - Proactive Proactive Investors

For further commentary and interviews, please visit the Destiny Pharma page at Proactive Investors on the link above